IP Library › Assignment 014548/0941
Patent Assignment
Reel/Frame 014548/0941

Assignment of Assignor's Interest

Recorded: 2003-10-01 Pages: 4
Assignor
AVENTIS PHARMA S.A.
Executed: 2003-08-01
Assignee
JONES PHARMA INCORPORATED
510 CUMBERLAND STREET, SUITE 200, BRISTOL, VIRGINIA, 24201
Covered Property (1)
Dalfopristine/Quinupristine Combinations with Cefpirome
Patent: 7,005,416 →
Application: 09/920,810 →
Publication: US 2002/0037890
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 4, 2001
From: FEGER, CELINE; MOREILLON, PHILIPPE; VOUILLAMOZ, JACQUES
To: AVENTIS PHARMA S.A.
Reel/Frame 012231/0574 →
Merger and Change of Name Mar 6, 2007
From: JONES PHARMA INCORPORATED
To: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC
Reel/Frame 018961/0829 →
Security Agreement Dec 30, 2008
From: KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC.
To: CREDIT SUISSE, AS AGENT
Reel/Frame 022034/0870 →
Release of Security Interest May 11, 2010
From: KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC.
To: CREDIT SUISSE AG
Reel/Frame 024369/0022 →